Inventor · disambiguated record
Soongyu Choi
Also filed as: CHOI SOONGYU
37 granted patents·11 pending applications·373 citations·filing 2001–2025
97Inventor score
Files withPTC THERAPEUTICS INC16BAYER PHARMACEUTICALS CORP8GREEN CROSS CORP6CHOI SOONGYU4AVELOS THERAPEUTICS INC2
Top patents by PatentIndex Score
48 records- 0196US7767689B2Carboline derivatives useful in the treatment of cancerPTC THERAPEUTICS INC·Filed 2005·Granted Aug 3, 2010·40 cites·12 claims
- 0295US9879007B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·18 cites·4 claims
- 0395US9371336B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Jun 21, 2016·36 cites·5 claims
- 0495US7601840B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2005·Granted Oct 13, 2009·39 cites·7 claims
- 0594US9617268B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2012·Granted Apr 11, 2017·32 cites·5 claims
- 0694US9586955B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Mar 7, 2017·22 cites·21 claims
- 0791US9701681B2Fused ring heteroaryl compounds and their use as Trk inhibitorsCMG PHARMACEUTICAL CO LTD·Filed 2015·Granted Jul 11, 2017·35 cites·19 claims
- 0889US8372860B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2010·Granted Feb 12, 2013·12 cites·21 claims
- 0989US8367694B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2009·Granted Feb 5, 2013·12 cites·23 claims
- 1088US10752697B2Anti-glypican 3 antibody and pharmaceutical composition containing the sameMOGAM INST BIOMEDICAL RES·Filed 2016·Granted Aug 25, 2020·6 cites·17 claims
- 1188US8143257B2Substituted phenols as active agents inhibiting VEGF productionCHOI SOONGYU·Filed 2005·Granted Mar 27, 2012·15 cites·8 claims
- 1287US6960601B2Preparation and use of imidazole derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Nov 1, 2005·26 cites·8 claims
- 1386US10851175B2Anti-mesothelin antibody and composition comprising the sameMOGAM INST BIOMEDICAL RES·Filed 2016·Granted Dec 1, 2020·5 cites·15 claims
- 1486US9340521B2Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivativesGREEN CROSS CORP·Filed 2013·Granted May 17, 2016·6 cites·5 claims
- 1586US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 1685US10640496B2Method for producing diphenylmethane derivativeDAE WOONG PHARMA·Filed 2017·Granted May 5, 2020·3 cites·4 claims
- 1785US9271960B2Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational controlPTC THERAPEUTICS INC·Filed 2015·Granted Mar 1, 2016·4 cites·4 claims
- 1884US10239873B27-azaindole or 4,7-diazaindole derivatives as IKKϵ epsilon and TBK1 inhibitor and pharmaceutical composition comprising sameGREEN CROSS CORP·Filed 2016·Granted Mar 26, 2019·4 cites·6 claims
- 1984US2024067646A1Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2082US9351964B2Methods for treating cancer and non-neoplastic conditionsALMSTEAD NEIL·Filed 2010·Granted May 31, 2016·6 cites·6 claims
- 2182US9034921B2Diphenylmethane derivatives as SGLT2 inhibitorsCHOI SOONGYU·Filed 2012·Granted May 19, 2015·9 cites·12 claims
- 2277US10889574B2Method for producing diphenylmethane derivativeDAE WOONG PHARMA·Filed 2019·Granted Jan 12, 2021·1 cites·15 claims
- 2377US8946444B2Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational controlLENNOX WILLIAM·Filed 2005·Granted Feb 3, 2015·4 cites·12 claims
- 2476US10294207B2Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising sameGREEN CROSS CORP·Filed 2016·Granted May 21, 2019·2 cites·1 claims
- 2571US11753407B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2020·Granted Sep 12, 2023·0 cites·13 claims
- 2671US10851101B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2019·Granted Dec 1, 2020·0 cites·9 claims
- 2771US10584115B2Substituted pyridine and pyrazine BMI-1 inhibitorsPTC THERAPEUTICS INC·Filed 2013·Granted Mar 10, 2020·1 cites·17 claims
- 2863US2018105526A1Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2961US7964622B2Indole acetic acid derivatives and their use as pharmaceutical agentsBAYER HEALTHCARE LLC·Filed 2009·Granted Jun 21, 2011·0 cites·13 claims
- 3060US9988372B2Crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising sameGREEN CROSS CORP·Filed 2014·Granted Jun 5, 2018·0 cites·4 claims
- 3158US2011160190A1Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 3257US2024300936A1Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agentsAVELOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3357US2025352549A1Substituted heterocyclic compound derivatives and their pharmaceutical useAVELOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3456US2010069380A1Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereofCHOI SOONGYU·Filed 2007·Application pending·0 cites
- 3552US7592361B2Indole acetic acid derivatives and their use as pharmaceutical agentsBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 22, 2009·0 cites·20 claims
- 3651US7714004B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2003·Granted May 11, 2010·0 cites·34 claims
- 3751US2011130397A1Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereofCHOI SOONGYU·Filed 2007·Application pending·0 cites
- 3850USRE47689ECompounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2012·Granted Nov 5, 2019·0 cites·7 claims
- 3950US2006122215A1Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 4049US7071207B2Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jul 4, 2006·0 cites·27 claims
- 4149US2005256167A1Preparation and use of imidazole derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 4243US7906653B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER HEALTHCARE LLC·Filed 2010·Granted Mar 15, 2011·0 cites·29 claims
- 4341US2005119246A11H-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptorBAYER PHARMACEUTICALS CORP·Filed 2002·Application pending·0 cites
- 4440US9371303B2Diphenylmethane derivatives as SGLT2 inhibitorsGREEN CROSS CORP·Filed 2015·Granted Jun 21, 2016·0 cites·8 claims
- 4540US2005119489A14-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptorFiled 2002·Application pending·0 cites
- 4639US9856216B2Compounds as TNIK, IKKε and TBK1 inhibitors and pharmaceutical composition comprising sameGREEN CROSS CORP·Filed 2016·Granted Jan 2, 2018·0 cites·14 claims
- 4738US8940896B2Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesisMOON YOUNG-CHOON·Filed 2005·Granted Jan 27, 2015·0 cites·9 claims
- 4836US8921412B2C-aryl ansa SGLT2 inhibitorsKIM MIN JU·Filed 2012·Granted Dec 30, 2014·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →